DESF

DRUG2 trials

Sponsors

Aquestive Therapeutics

Conditions

Allergic Reaction

Phase 1

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of DESF in Pediatric Subjects

CompletedNCT07703982

Aquestive TherapeuticsAllergic Reaction

Start: 2024-12-26End: 2025-05-21Updated: 2026-07-15

Phase 2

Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome

CompletedNCT06527937

Aquestive TherapeuticsAllergic Reaction

Start: 2024-07-17End: 2024-10-13Updated: 2025-09-26